What is the therapeutic radioisotopes market size?

The therapeutic radioisotopes market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the therapeutic radioisotopes market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the therapeutic radioisotopes market?

Key drivers include rising cancer incidence and technological advancements in radioisotope production.

What are the challenges facing the therapeutic radioisotopes market?

Challenges include high production costs and regulatory hurdles, impacting market growth.

Which regions are leading the therapeutic radioisotopes market?

North America and Europe are regional leaders, accounting for over 60% of the market share.

Who are the top companies in the therapeutic radioisotopes market?

Top companies include GE Healthcare, Siemens Healthineers, and Curium, driving innovation and growth.

What are the future opportunities in the therapeutic radioisotopes market?

Future opportunities include emerging applications in targeted therapies and increasing adoption in developing economies.

How is technology impacting the therapeutic radioisotopes market?

Advances in technology are improving radioisotope production efficiency and reducing costs, enhancing market prospects.

What is the regulatory landscape for the therapeutic radioisotopes market?

The regulatory landscape is complex, with stringent safety and quality control regulations governing market operations.

What is the future outlook for the therapeutic radioisotopes market?

The future outlook is positive, with growing demand and increasing adoption of therapeutic radioisotopes in cancer treatment.

Which Companies Lead the therapeutic radioisotopes Market in 2026?

therapeutic radioisotopes by Application (Thyroid, Bone Metastasis, Lymphoma, Other), by Types (Radium-223, Lutetium-177, Iodine-131, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $7.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $7.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

therapeutic radioisotopes Market Size | CAGR 10.2 Forecast 2033

Which Companies Lead the therapeutic radioisotopes Market in 2026?

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $7.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $7.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

therapeutic radioisotopes Market Overview

The therapeutic radioisotopes market refers to the industry that develops and supplies radioactive isotopes for medical treatment purposes. As the global healthcare sector continues to evolve, the therapeutic radioisotopes market size is expected to experience significant growth, driven by increasing demand for targeted and effective cancer treatments. The growth outlook for the therapeutic radioisotopes market is promising, with a projected market size of approximately $1.6 billion in 2026. The market forecast indicates a compound annual growth rate (CAGR) of around 8-10% during the forecast period from 2026 to 2033, driven by advancements in nuclear medicine and radiopharmaceuticals. The industry expansion is expected to be driven by key forces such as technology shifts, regulatory approvals, and competitive intensity.

Loading chart…

The largest region in the therapeutic radioisotopes market is North America, driven by the presence of major players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for cancer treatments and government initiatives to improve healthcare access. Key forces shaping the industry include technology shifts towards more targeted and effective treatments, regulatory approvals for new radiopharmaceuticals, and competitive intensity among market players. Overall, the therapeutic radioisotopes market is expected to experience significant growth and industry expansion during the forecast period, driven by increasing demand for effective cancer treatments and advancements in nuclear medicine.

Report Overview

Report Attribute	Details
Market size value in 2025	7.80 million
Revenue forecast in 2033	16.96 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Novartis; China Isotope & Radiation; Dongcheng; Q BioMed; Curium Pharmaceuticals; Jubilant DraxImage; Lantheus; Spectrum Pharmaceuticals; Progenics Pharmaceuticals; International Isotopes
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The therapeutic radioisotopes market is poised for significant growth, driven by increasing demand for targeted therapies and advancements in nuclear medicine. The therapeutic radioisotopes market size is expected to expand rapidly, with a substantial growth forecast over the next five years.

Growth Drivers2 items

Advances in technology, such as improved radiation therapy equipment and isotope production methods, are driving the adoption of therapeutic radioisotopes, leading to increased market size and growth forecast

Growing cancer incidence rates and an aging population are fueling the demand for effective and targeted therapies, contributing to the expansion of the therapeutic radioisotopes market

Restraints2 items

Stringent regulatory requirements and high production costs are limiting the availability of therapeutic radioisotopes, hindering market growth and impacting the overall growth forecast

Competition from alternative treatments and therapies is also restraining the growth of the therapeutic radioisotopes market, affecting market size and share

Opportunities2 items

Emerging markets and increasing investment in nuclear medicine infrastructure are creating new opportunities for the therapeutic radioisotopes market, driving growth and expansion

The development of new isotopes and applications is expected to further drive the growth of the therapeutic radioisotopes market, enhancing market size and growth forecast

Challenges2 items

Ensuring a stable supply chain and managing cost pressures are significant challenges facing the therapeutic radioisotopes market, impacting market growth and stability

Addressing safety concerns and maintaining quality standards are also crucial challenges that must be addressed to ensure the long-term sustainability of the therapeutic radioisotopes market and support the growth forecast

Market Segmentation

Loading chart…

The therapeutic radioisotopes market can be segmented based on application, which refers to the specific use of radioisotopes in various medical treatments. This segmentation category contributes to the overall market size by highlighting the demand for radioisotopes in different therapeutic areas. The application segment includes subtypes such as cancer treatment, pain management, and cardiovascular diseases, among others. Understanding the therapeutic radioisotopes segmentation is crucial for market players to identify growth opportunities and develop targeted strategies.

Another key segmentation category in the therapeutic radioisotopes market is types, which refers to the different types of radioisotopes used in medical treatments. This segment includes subtypes such as beta emitters, alpha emitters, and brachytherapy seeds, among others. The types segment contributes to the overall market size by highlighting the demand for specific radioisotopes and their respective applications. Analyzing the market taxonomy of therapeutic radioisotopes is essential for industry players to understand the competitive landscape and develop effective market strategies.

therapeutic radioisotopes Segmentation Breakdown10 items

Application

Thyroid

Bone Metastasis

Lymphoma

Other

Types

Radium-223

Lutetium-177

Iodine-131

Other

Regional Insights

Loading chart…

The therapeutic radioisotopes market growth is expected to vary across regions, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. North America is the largest region, accounting for approximately 40% of the market, driven by key drivers such as high adoption of cancer treatments, favorable policies and regulations, and significant investments in research and development.

The fastest-growing region is Asia Pacific, driven by key drivers such as increasing demand for cancer treatments, growing infrastructure and ecosystem maturity, and rising investments in healthcare. Europe is also a significant region, driven by key drivers such as high adoption of therapeutic radioisotopes, favorable policies and regulations, and significant investments in research and development. Latin America and Middle East & Africa are also expected to contribute to the regional forecast, driven by key drivers such as growing demand for cancer treatments and increasing infrastructure and ecosystem maturity.

Key Drivers by Region5 items

North America: high adoption of cancer treatments, favorable policies and regulations, significant investments in research and development

Europe: high adoption of therapeutic radioisotopes, favorable policies and regulations, significant investments in research and development

Asia Pacific: increasing demand for cancer treatments, growing infrastructure and ecosystem maturity, rising investments in healthcare

Latin America: growing demand for cancer treatments, increasing infrastructure and ecosystem maturity

Middle East & Africa: growing demand for cancer treatments, increasing infrastructure and ecosystem maturity

Competitive Landscape

The therapeutic radioisotopes market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The therapeutic radioisotopes competitive landscape is driven by the ability of companies to navigate complex regulatory environments and establish strong distribution networks. Global players tend to focus on high-value products and markets, while local companies often prioritize regional expansion and customization.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must develop unique value propositions, such as technology advancements, service model innovations, or cost advantages. The following companies illustrate different strategic focuses:

Bayer: regional expansion

Novartis: innovation pipeline

China Isotope & Radiation: local manufacturing

Dongcheng: OEM tie-ups

Q BioMed: premium pricing

Curium Pharmaceuticals: vertical integration

Key therapeutic radioisotopes Companies11 items

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Lantheus

Spectrum Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

Market Ecosystem

The therapeutic radioisotopes ecosystem encompasses a complex network of stakeholders, spanning upstream, midstream, and downstream segments. It involves technology providers and suppliers, integrators, channels, and end users, all contributing to the creation and capture of value. Understanding this ecosystem is crucial for conducting a thorough value chain analysis, as it reveals how different participants interact and influence one another.

Raw material suppliers — providing isotopes and precursors

Technology providers — developing production and processing technologies

OEMs / manufacturers — producing radioisotope-based products

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing therapeutic radioisotopes in medical treatments

Regulators/standards bodies — overseeing safety and efficacy standards

In the therapeutic radioisotopes ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate safety and efficacy standards. Dependency risks arise from input constraints, such as limited isotope supply, and approvals from regulatory bodies. Switching costs and partnerships are also significant, as they can impact the availability and adoption of therapeutic radioisotopes. Furthermore, the ecosystem differs by region, with varying regulatory frameworks and market demands, highlighting the need for a nuanced understanding of the therapeutic radioisotopes ecosystem.

Recent Industry Insights

The therapeutic radioisotopes industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading pharmaceutical companies and research institutions have accelerated the development of new radioisotope-based treatments. Notable mergers and acquisitions have also taken place, with companies expanding their product portfolios and strengthening their market presence. Furthermore, several product and technology launches have improved the accessibility and efficacy of therapeutic radioisotopes, catering to the growing demand for targeted cancer therapies.

In addition to these developments, regulatory changes have played a crucial role in shaping the therapeutic radioisotopes industry trends. Shifts in consumer and enterprise trends have led to increased investments in research and development, with several funding rounds and expansions announced in the last year. These advancements are expected to drive growth in the therapeutic radioisotopes market, providing new opportunities for patients and healthcare providers alike.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the therapeutic radioisotopes market outlook. The market attractiveness is moderate, driven by increasing demand for targeted therapies and a growing patient population. Competitive intensity is high, with key players investing heavily in research and development to expand their product portfolios.

The long-term outlook is promising, with opportunities for innovation in radioisotope production and cancer treatment. However, the demand–supply balance is a concern, with potential shortages of critical radioisotopes. Key risk factors include regulatory changes, supply chain disruptions, and technological advancements. Overall, the therapeutic radioisotopes market is poised for growth, driven by advances in medical technology and an increasing focus on personalized medicine.

12 items

1. Executive Summary

2. therapeutic radioisotopes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global therapeutic radioisotopes Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global therapeutic radioisotopes Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global therapeutic radioisotopes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global therapeutic radioisotopes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global therapeutic radioisotopes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global therapeutic radioisotopes Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global therapeutic radioisotopes Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global therapeutic radioisotopes Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global therapeutic radioisotopes Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global therapeutic radioisotopes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global therapeutic radioisotopes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global therapeutic radioisotopes Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global therapeutic radioisotopes Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global therapeutic radioisotopes Market Competition by Key Manufacturers

9.1. Global therapeutic radioisotopes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global therapeutic radioisotopes: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bayer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Novartis

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. China Isotope & Radiation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Dongcheng

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Q BioMed

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Curium Pharmaceuticals

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Jubilant DraxImage

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Lantheus

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Spectrum Pharmaceuticals

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Progenics Pharmaceuticals

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. International Isotopes

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global therapeutic radioisotopes Market

Figure 4: Global therapeutic radioisotopes Market: Drivers

Figure 5: Global therapeutic radioisotopes Market: Challenges

Figure 6: Global therapeutic radioisotopes Market: Trends

Figure 7: Global therapeutic radioisotopes Market: Opportunity

Figure 8: Global therapeutic radioisotopes Market: Restraint

Figure 9: Global therapeutic radioisotopes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global therapeutic radioisotopes Market Value (USD Million) By Region

Figure 19: Global therapeutic radioisotopes Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global therapeutic radioisotopes Market Value (USD Million) By Region

Figure 27: Global therapeutic radioisotopes Market Share (%) By: Regions (2032)

Figure 28: Global therapeutic radioisotopes Market Volume (K) By Region

Figure 29: Global therapeutic radioisotopes Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global therapeutic radioisotopes Market Value (USD Million) By Region

Figure 37: Global therapeutic radioisotopes Market Share (%) By: Regions (2032)

Figure 38: Global therapeutic radioisotopes Market Volume (K) By Region

Figure 39: Global therapeutic radioisotopes Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global therapeutic radioisotopes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global therapeutic radioisotopes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global therapeutic radioisotopes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global therapeutic radioisotopes Market Value (USD Million) By Region

Table 14: Global therapeutic radioisotopes Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global therapeutic radioisotopes Market Volume (K) By Region

Table 31: Global therapeutic radioisotopes Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global therapeutic radioisotopes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global therapeutic radioisotopes Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global therapeutic radioisotopes Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bayer Basic Information And Sales Area

Table 52: Bayer. Products Portfolio

Table 53: Novartis Basic Information And Sales Area

Table 54: Novartis. Products Portfolio

Table 55: China Isotope & Radiation Basic Information And Sales Area

Table 56: China Isotope & Radiation. Products Portfolio

Table 57: Dongcheng Basic Information And Sales Area

Table 58: Dongcheng. Products Portfolio

Table 59: Q BioMed Basic Information And Sales Area

Table 60: Q BioMed. Products Portfolio

Table 61: Curium Pharmaceuticals Basic Information And Sales Area

Table 62: Curium Pharmaceuticals. Products Portfolio

Table 63: Jubilant DraxImage Basic Information And Sales Area

Table 64: Jubilant DraxImage. Products Portfolio

Table 65: Lantheus Basic Information And Sales Area

Table 66: Lantheus. Products Portfolio

Table 67: Spectrum Pharmaceuticals Basic Information And Sales Area

Table 68: Spectrum Pharmaceuticals. Products Portfolio

Table 69: Progenics Pharmaceuticals Basic Information And Sales Area

Table 70: Progenics Pharmaceuticals. Products Portfolio

Table 71: International Isotopes Basic Information And Sales Area

Table 72: International Isotopes. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global therapeutic radioisotopes Market Value (USD Million) By Region

Table 82: Global therapeutic radioisotopes Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global therapeutic radioisotopes Market Volume (K) By Region

Table 99: Global therapeutic radioisotopes Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

therapeutic radioisotopes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	7.80 million
Revenue forecast in 2033	16.96 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Novartis; China Isotope & Radiation; Dongcheng; Q BioMed; Curium Pharmaceuticals; Jubilant DraxImage; Lantheus; Spectrum Pharmaceuticals; Progenics Pharmaceuticals; International Isotopes
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options